| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Using serum or infected blood from Danish volunteers and Plasmodium falciparum-infected Mozambican patients, respectively, the impact of curative doses of chloroquine and pyrimethamine/sulfadoxine upon infectivity of P. falciparum to Anopheles arabiensis and An. gambiae or of P. berghei to An. stephensi was studied. Both treatments cleared circulating P. falciparum gametocytes within 28 days. Before this clearance, chloroquine enhanced infectivity to An. arabiensis, whereas pyrimethamine/sulfadoxine decreased infectivity. Patients harboring chloroquine-resistant parasites as opposed to -sensitive ones were 4.4 times more likely to have gametocytes following treatment. In contrast, pyrimethamine/sulfadoxine-resistant parasites were 1.9 times less likely to produce gametocytes. In laboratory infections using replicated P. berghei or P. falciparum preparations, serum from chloroquine-treated, uninfected, nonimmune volunteers enhanced gametocyte infectivity with increasing efficiency for 21 days following treatment, whereas pyrimethamine/sulfadoxine significantly suppressed infectivity. The observed enhancement in infectivity induced by the use of chloroquine combined with increased gametocytemias in chloroquine-resistant strains may in part explain the rapid spread of chloroquine resistance in endemic populations.
This article has been cited by other articles:
|
|
 |
|
  S. Eksi, B. Czesny, G.-J. van Gemert, R. W. Sauerwein, W. Eling, and K. C. Williamson Inhibition of Plasmodium falciparum Oocyst Production by Membrane-Permeant Cysteine Protease Inhibitor E64d Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1064 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. BOUDIN, A. DIOP, A. GAYE, L. GADIAGA, C. GOUAGNA, I. SAFEUKUI, and S. BONNET PLASMODIUM FALCIPARUM TRANSMISSION BLOCKING IMMUNITY IN THREE AREAS WITH PERENNIAL OR SEASONAL ENDEMICITY AND DIFFERENT LEVELS OF TRANSMISSION Am J Trop Med Hyg, December 1, 2005; 73(6): 1090 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. TALMAN, R. E. L. PAUL, C. S. SOKHNA, O. DOMARLE, F. ARIEY, J.-F. TRAPE, and V. ROBERT INFLUENCE OF CHEMOTHERAPY ON THE PLASMODIUM GAMETOCYTE SEX RATIO OF MICE AND HUMANS Am J Trop Med Hyg, December 1, 2004; 71(6): 739 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. SUTANTO, S. SUPRIYANTO, P. RUCKERT, PURNOMO, J. D. MAGUIRE, and M. J. BANGS COMPARATIVE EFFICACY OF CHLOROQUINE AND SULFADOXINE-PYRIMETHAMINE FOR UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA AND IMPACT ON GAMETOCYTE CARRIAGE RATES IN THE EAST NUSATENGGARA PROVINCE OF INDONESIA Am J Trop Med Hyg, May 1, 2004; 70(5): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. BASCO MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XVI. LONGITUDINAL SURVEILLANCE OF IN VITRO PYRIMETHAMINE RESISTANCE IN PLASMODIUM FALCIPARUM Am J Trop Med Hyg, August 1, 2003; 69(2): 174 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. ZUCKER, T. K. RUEBUSH II, C. OBONYO, J. OTIENO, and C. C. CAMPBELL THE MORTALITY CONSEQUENCES OF THE CONTINUED USE OF CHLOROQUINE IN AFRICA: EXPERIENCE IN SIAYA, WESTERN KENYA Am J Trop Med Hyg, April 1, 2003; 68(4): 386 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. BUTCHER and R. E. SINDEN PERSISTENCE OF ATOVAQUONE IN HUMAN SERA FOLLOWING TREATMENT: INHIBITION OF P. FALCIPARUM DEVELOPMENT IN VIVO AND IN VITRO Am J Trop Med Hyg, January 1, 2003; 68(1): 111 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tjitra, S. Suprianto, J. McBroom, B. J. Currie, and N. M. Anstey Persistent ICT Malaria P.f/P.v Panmalarial and HRP2 Antigen Reactivity after Treatment of Plasmodium falciparum Malaria Is Associated with Gametocytemia and Results in False-Positive Diagnoses of Plasmodium vivax in Convalescence J. Clin. Microbiol., March 1, 2001; 39(3): 1025 - 1031. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
